arrow
G

Guilherme Nader Marta

University of Genoa
H指数:16
被引数:899

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TLSB-19 CENTRAL NERVOUS SYSTEM DISSEMINATION IN METASTATIC LOBULAR BREAST CANCER: A HISTOLOGY-BASED ANALYSIS

TLSB-19 弥漫性转移性小叶乳腺癌的中枢神经系统扩散:基于组织学的分析

2026-08-070
OA
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study

内分泌治疗联合CDK4/6抑制剂后进展的ER阳性/HER2阴性晚期乳腺癌中依维莫司的有效性:EVERGREEN研究

2026-07-100
PRE
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2− breast cancer: a randomized phase 2 trial

durvalumab和oleclumab新辅助立体定向放射治疗ER HER2 − 乳腺癌: 一项随机2期试验

2026-06-250
OAAI
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial

HER2低表达乳腺癌的密集剂量辅助化疗:GIM2试验的探索性分析

Breast
IF7.9
2026-06-010
OA
PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial

PSMA靶向PET成像在转移性三阴性乳腺癌患者中的应用:PRISMA前瞻性试验的结果

2025-11-280
PRE
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

早期三阴性乳腺癌中视觉和计算评估的肿瘤浸润淋巴细胞预后价值(TBCRC-030)

2025-11-010
PRE
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer

浸润性小叶乳腺癌患者的临床挑战和建议的解决方案

2025-07-210
OAAI
Topical steroids for the prevention of radiation dermatitis in breast cancer: A systematic review and network meta-analyses of randomised controlled trials

外用糖皮质激素预防乳腺癌放射皮炎:一项随机对照试验的系统评价和网络Meta分析

2024-12-010
PRE
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
2024-10-070
OAAI
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
2024-10-010
OAAI
Subtype-specific prognostic value of lobular histology in patients with early-stage breast cancer: A nationwide population-based study

小叶组织学在早期乳腺癌患者中的亚型特异性预后价值:一项全国性基于人群的研究

2024-09-010
PRE
EVERolimus effectiveness after proGREssion on CDK4/6 inhibitors for ENdocrine receptor-positive/HER2-negative, advanced breast cancer: EVERGREEN quasi-experimental study

依维莫司在CDK4/6抑制剂进展后的内分泌受体阳性/HER2阴性晚期乳腺癌中的疗效:EVERGREEN准实验研究

2024-09-010
PRE